Skip to main navigation

Overview
Corporate
News & Events
Stock Information
Financial Information
- SEC Filings
- Quarterly Results
IR Resources

News & Events

News Releases

News Releases

All
2022
2021
2020
2019

2020.01.08

Adagene Completes $69 Million Series D Financing Led by Growth Investor General Atlantic

2019.10.26

Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences

2019.04.24

Adagene and ADC Therapeutics Announce SAFEbody™ License Agreement

2019.03.04

Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation

2019.01.07

Adagene Announces Collaboration for Discovery of Novel CAR-T with the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH)

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Current page 10

Displaying 46 - 50 of 50

Shareholder Tools

© 2022 Adagene Inc.

Footer Bottom

Home
Privacy
Terms of Use
Contact
Site Credits
LinkedIn